ATE345821T1 - Radionuklide enthaltendes silikon-implantat für brachytherapie - Google Patents
Radionuklide enthaltendes silikon-implantat für brachytherapieInfo
- Publication number
- ATE345821T1 ATE345821T1 AT02700440T AT02700440T ATE345821T1 AT E345821 T1 ATE345821 T1 AT E345821T1 AT 02700440 T AT02700440 T AT 02700440T AT 02700440 T AT02700440 T AT 02700440T AT E345821 T1 ATE345821 T1 AT E345821T1
- Authority
- AT
- Austria
- Prior art keywords
- silicon
- brachytherapy
- cancer
- implant containing
- silicone implant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Pregnancy & Childbirth (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0104383.5A GB0104383D0 (en) | 2001-02-22 | 2001-02-22 | Cancer Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE345821T1 true ATE345821T1 (de) | 2006-12-15 |
Family
ID=9909289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02700440T ATE345821T1 (de) | 2001-02-22 | 2002-02-20 | Radionuklide enthaltendes silikon-implantat für brachytherapie |
Country Status (11)
Country | Link |
---|---|
US (6) | US8097236B2 (de) |
EP (2) | EP1844794B1 (de) |
JP (2) | JP4594587B2 (de) |
AT (1) | ATE345821T1 (de) |
AU (1) | AU2002233513B2 (de) |
CA (1) | CA2439062C (de) |
DE (1) | DE60216234T2 (de) |
ES (1) | ES2275831T3 (de) |
GB (1) | GB0104383D0 (de) |
NZ (1) | NZ527363A (de) |
WO (1) | WO2002067998A2 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4009618A1 (de) * | 1990-03-26 | 1991-10-02 | Henkel Kgaa | Spruehgetrocknetes, avivierend wirkendes waschmitteladditiv |
GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
GB0130608D0 (en) | 2001-12-21 | 2002-02-06 | Psimedica Ltd | Medical fibres and fabrics |
GB2399014A (en) * | 2003-01-31 | 2004-09-08 | Psimedica Ltd | Device comprising resorbable silicon for boron neutron capture therapy |
GB0324483D0 (en) | 2003-10-21 | 2003-11-19 | Psi Medica Ltd | Composite material |
EP1677828B1 (de) * | 2003-10-21 | 2012-12-26 | PSIMedica Limited | Verbundmaterial mit einem porösen, mit einer organischen substanz beschichteten halbleiter |
GB2409924A (en) * | 2004-01-06 | 2005-07-13 | Psimedica Ltd | Method of making a silicon-phosphorus composite |
EP1817003B1 (de) | 2004-10-29 | 2018-02-21 | The Regents of The University of California | Poröse silicium-micropartikeln zur verabreichung von wirkstoffen ins auge |
US7526058B2 (en) * | 2004-12-03 | 2009-04-28 | General Electric Company | Rod assembly for nuclear reactors |
ITNA20040067A1 (it) * | 2004-12-03 | 2005-03-03 | Consiglio Nazionale Ricerche | Immobilizzazione di biomolecole su supporti porosi, tramite fascio elettronici, per applicazioni in campo biomedico ed elettronico. |
US8953731B2 (en) | 2004-12-03 | 2015-02-10 | General Electric Company | Method of producing isotopes in power nuclear reactors |
US8920625B2 (en) * | 2007-04-27 | 2014-12-30 | Board Of Regents Of The University Of Texas System | Electrochemical method of making porous particles using a constant current density |
JP6067207B2 (ja) * | 2007-07-10 | 2017-01-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 選択した組織へ組成物を送達するための材料と方法 |
US9362009B2 (en) * | 2007-11-28 | 2016-06-07 | Ge-Hitachi Nuclear Energy Americas Llc | Cross-section reducing isotope system |
US20090135990A1 (en) * | 2007-11-28 | 2009-05-28 | Ge-Hitachi Nuclear Energy Americas Llc | Placement of target rods in BWR bundle |
US9202598B2 (en) * | 2007-11-28 | 2015-12-01 | Ge-Hitachi Nuclear Energy Americas Llc | Fail-free fuel bundle assembly |
US8842800B2 (en) * | 2007-11-28 | 2014-09-23 | Ge-Hitachi Nuclear Energy Americas Llc | Fuel rod designs using internal spacer element and methods of using the same |
US20090135989A1 (en) * | 2007-11-28 | 2009-05-28 | Ge-Hitachi Nuclear Energy Americas Llc | Segmented fuel rod bundle designs using fixed spacer plates |
US8437443B2 (en) | 2008-02-21 | 2013-05-07 | Ge-Hitachi Nuclear Energy Americas Llc | Apparatuses and methods for production of radioisotopes in nuclear reactor instrumentation tubes |
US8712000B2 (en) | 2007-12-13 | 2014-04-29 | Global Nuclear Fuel—Americas, LLC | Tranverse in-core probe monitoring and calibration device for nuclear power plants, and method thereof |
US8885791B2 (en) | 2007-12-18 | 2014-11-11 | Ge-Hitachi Nuclear Energy Americas Llc | Fuel rods having irradiation target end pieces |
US8180014B2 (en) | 2007-12-20 | 2012-05-15 | Global Nuclear Fuel-Americas, Llc | Tiered tie plates and fuel bundles using the same |
US7970095B2 (en) | 2008-04-03 | 2011-06-28 | GE - Hitachi Nuclear Energy Americas LLC | Radioisotope production structures, fuel assemblies having the same, and methods of using the same |
US8050377B2 (en) | 2008-05-01 | 2011-11-01 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation target retention systems, fuel assemblies having the same, and methods of using the same |
US8270555B2 (en) * | 2008-05-01 | 2012-09-18 | Ge-Hitachi Nuclear Energy Americas Llc | Systems and methods for storage and processing of radioisotopes |
US7781637B2 (en) * | 2008-07-30 | 2010-08-24 | Ge-Hitachi Nuclear Energy Americas Llc | Segmented waste rods for handling nuclear waste and methods of using and fabricating the same |
US8699651B2 (en) | 2009-04-15 | 2014-04-15 | Ge-Hitachi Nuclear Energy Americas Llc | Method and system for simultaneous irradiation and elution capsule |
US9165691B2 (en) * | 2009-04-17 | 2015-10-20 | Ge-Hitachi Nuclear Energy Americas Llc | Burnable poison materials and apparatuses for nuclear reactors and methods of using the same |
AU2010246067B2 (en) | 2009-05-04 | 2016-07-07 | Eyepoint Pharmaceuticals Us, Inc. | Porous silicon drug-eluting particles |
US9431138B2 (en) * | 2009-07-10 | 2016-08-30 | Ge-Hitachi Nuclear Energy Americas, Llc | Method of generating specified activities within a target holding device |
US8366088B2 (en) * | 2009-07-10 | 2013-02-05 | Ge-Hitachi Nuclear Energy Americas Llc | Brachytherapy and radiography target holding device |
US8638899B2 (en) * | 2009-07-15 | 2014-01-28 | Ge-Hitachi Nuclear Energy Americas Llc | Methods and apparatuses for producing isotopes in nuclear fuel assembly water rods |
US9183959B2 (en) * | 2009-08-25 | 2015-11-10 | Ge-Hitachi Nuclear Energy Americas Llc | Cable driven isotope delivery system |
US9773577B2 (en) * | 2009-08-25 | 2017-09-26 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation targets for isotope delivery systems |
US8488733B2 (en) | 2009-08-25 | 2013-07-16 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation target retention assemblies for isotope delivery systems |
US8542789B2 (en) * | 2010-03-05 | 2013-09-24 | Ge-Hitachi Nuclear Energy Americas Llc | Irradiation target positioning devices and methods of using the same |
US9899107B2 (en) | 2010-09-10 | 2018-02-20 | Ge-Hitachi Nuclear Energy Americas Llc | Rod assembly for nuclear reactors |
AU2011323524B2 (en) | 2010-11-01 | 2016-12-08 | Eyepoint Pharmaceuticals Us, Inc. | Bioerodible silicon-based devices for delivery of therapeutic agents |
US10350431B2 (en) | 2011-04-28 | 2019-07-16 | Gt Medical Technologies, Inc. | Customizable radioactive carriers and loading system |
WO2012166804A1 (en) | 2011-06-03 | 2012-12-06 | Reverse Medical Corporation | Embolic implant and method of use |
RU2695536C2 (ru) * | 2013-03-12 | 2019-07-23 | Айпоинт Фармасьютикалз Юэс, Инк. | Устройство для доставки лекарственных средств, содержащее частицы носителя на основе кремния |
US9492683B2 (en) | 2013-03-15 | 2016-11-15 | Gammatile Llc | Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors |
AU2014235051B2 (en) | 2013-03-15 | 2019-01-17 | Eyepoint Pharmaceuticals Us, Inc. | Bioerodible silicon-based compositions for delivery of therapeutic agents |
US9694201B2 (en) | 2014-04-24 | 2017-07-04 | Covidien Lp | Method of use of an embolic implant for radio-ablative treatment |
GB2529409A (en) * | 2014-08-18 | 2016-02-24 | Nexeon Ltd | Electroactive materials for metal-ion batteries |
ES2756301T3 (es) | 2014-08-19 | 2020-04-27 | Univ California | Implantes de administración localizada de fármacos y métodos de uso de los mismos |
US9821174B1 (en) | 2015-02-06 | 2017-11-21 | Gammatile Llc | Radioactive implant planning system and placement guide system |
US10702474B2 (en) | 2015-07-09 | 2020-07-07 | The Regents Of The University Of California | Fusogenic liposome-coated porous silicon nanoparticles |
US10888710B1 (en) | 2016-11-29 | 2021-01-12 | Gt Medical Technologies, Inc. | Transparent loading apparatus |
SG11202005947RA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
WO2019226519A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
US10981018B2 (en) | 2019-02-14 | 2021-04-20 | Gt Medical Technologies, Inc. | Radioactive seed loading apparatus |
CN114667162A (zh) | 2019-09-16 | 2022-06-24 | Abk生物医学公司 | 放射性微粒和非放射性微粒的组合物 |
US11338119B2 (en) | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11173291B2 (en) | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US20210338265A1 (en) * | 2020-04-30 | 2021-11-04 | Ethicon, Inc. | Methods and devices for delivering cancer therapy to a target tissue site via a cored tissue cavity |
CN114652865A (zh) * | 2020-12-23 | 2022-06-24 | 成都纽瑞特医疗科技股份有限公司 | 一种放射性玻璃微球注射剂及制备方法和用途 |
CN114652864A (zh) * | 2020-12-23 | 2022-06-24 | 成都纽瑞特医疗科技股份有限公司 | 一种放射性硅微粒注射剂及制备方法和用途 |
FR3129844A1 (fr) * | 2021-12-08 | 2023-06-09 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Sonde d'illumination implantable |
US12053644B2 (en) | 2021-12-30 | 2024-08-06 | Gt Medical Technologies, Inc. | Radiation shielding apparatus for implantable radioactive seeds |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5944310A (ja) * | 1982-09-06 | 1984-03-12 | Nippon Kayaku Co Ltd | シリコ−ンゴム系徐放性製剤 |
JPS59101145A (ja) | 1982-11-30 | 1984-06-11 | 日本特殊陶業株式会社 | 薬液含浸多孔質セラミツクス |
GB8422876D0 (en) * | 1984-09-11 | 1984-10-17 | Secr Defence | Silicon implant devices |
US4994013A (en) * | 1988-07-28 | 1991-02-19 | Best Industries, Inc. | Pellet for a radioactive seed |
EP0407623A1 (de) | 1989-02-01 | 1991-01-16 | Institut Fizicheskoi Khimii Imeni L.V.Pisarzhevskogo Akademii Nauk Ukrainskoi Ssr | Derivate von platin (p) mit methylsilikon, verfahren zur herstellung und anti-tumor-agens daraus |
US5256765A (en) | 1989-03-09 | 1993-10-26 | The Johns Hopkins University School Of Medicine | Biodegradable poly(phosphate esters) |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
AU2333892A (en) | 1992-01-31 | 1993-09-01 | Trustees Of Columbia University In The City Of New York, The | Taxol as a radiation sensitizer |
WO1994002068A1 (en) | 1992-07-21 | 1994-02-03 | The General Hospital Corporation | System of drug delivery to the lymphatic tissues |
DK170123B1 (da) * | 1993-06-04 | 1995-05-29 | Man B & W Diesel Gmbh | Fremgangsmåde til mindskning af ekstraspændinger fra torsionssvingninger i en hovedaksel til en stor totakts dieselmotor |
DE69435342D1 (de) | 1993-07-19 | 2011-05-05 | Angiotech Pharm Inc | Anti-Angiogene Mittel und Verfahren zu deren Verwendung |
WO1998017331A1 (en) * | 1995-06-07 | 1998-04-30 | Cook Incorporated | Silver implantable medical device |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
GB9611437D0 (en) * | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
AU712953B2 (en) | 1996-03-11 | 1999-11-18 | Focal, Inc. | Polymeric delivery of radionuclides and radiopharmaceuticals |
US6241962B1 (en) * | 1996-06-24 | 2001-06-05 | Dupont Pharmaceuticals Company | Radiopharmaceutical compositions and matrices and uses thereof |
US5795286A (en) | 1996-08-15 | 1998-08-18 | Cathco, Inc. | Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation |
US5871437A (en) | 1996-12-10 | 1999-02-16 | Inflow Dynamics, Inc. | Radioactive stent for treating blood vessels to prevent restenosis |
US5894133A (en) * | 1996-12-18 | 1999-04-13 | Implant Science Corporation | Sputter cathode for application of radioactive material |
JP2001521503A (ja) | 1997-03-31 | 2001-11-06 | ネオルックス コーポレイション | 血管平滑筋細胞の治療的阻害物質 |
CZ298765B6 (cs) | 1997-06-19 | 2008-01-23 | European Organization For Nuclear Research | Způsob exponování materiálu neutronovým tokem, způsob produkování užitečného izotopu zahrnující uvedený způsob exponování a způsob transmutace alespoň jednoho dlouhodobého izotopuzahrnující uvedený způsob exponování |
JP2002501001A (ja) | 1998-01-22 | 2002-01-15 | パーデュー・リサーチ・ファウンデーション | 官能性多孔性珪素表面 |
US6060036A (en) | 1998-02-09 | 2000-05-09 | Implant Sciences Corporation | Radioactive seed implants |
GB9808052D0 (en) * | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
GB9815819D0 (en) * | 1998-07-22 | 1998-09-16 | Secr Defence | Transferring materials into cells and a microneedle array |
JP2002524108A (ja) * | 1998-07-28 | 2002-08-06 | インナーダイン, インコーポレイテッド | 吸収性近接照射療法および化学療法送達デバイスならびに方法 |
US6676595B1 (en) * | 1998-08-24 | 2004-01-13 | Varian Medical Systems Technologies, Inc. | Radioactive medical implant and method of manufacturing |
US6379648B1 (en) | 1999-02-01 | 2002-04-30 | The Curators Of The University Of Missouri | Biodegradable glass compositions and methods for radiation therapy |
AU4176300A (en) * | 1999-04-02 | 2000-10-23 | Ut-Battelle, Llc | Indium-114m as a source for brachytherapy and related compositions and methods |
EP1175233B1 (de) * | 1999-05-01 | 2004-02-25 | PSIMEDICA Limited | Derivatisiertes poröses silicium |
EP1235598A2 (de) * | 1999-11-12 | 2002-09-04 | Angiotech Pharmaceuticals, Inc. | Zusammensetzung von ein kombination von radioaktive therapie und zellzyklus inhibitoren |
EP2332542B1 (de) * | 1999-12-06 | 2015-02-11 | Geistlich Pharma AG | Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von tumoren |
US6575888B2 (en) | 2000-01-25 | 2003-06-10 | Biosurface Engineering Technologies, Inc. | Bioabsorbable brachytherapy device |
GB2363115A (en) * | 2000-06-10 | 2001-12-12 | Secr Defence | Porous or polycrystalline silicon orthopaedic implants |
AU2003267309A1 (en) * | 2000-11-16 | 2004-04-08 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
-
2001
- 2001-02-22 GB GBGB0104383.5A patent/GB0104383D0/en not_active Ceased
-
2002
- 2002-02-20 CA CA2439062A patent/CA2439062C/en not_active Expired - Lifetime
- 2002-02-20 US US10/468,742 patent/US8097236B2/en not_active Expired - Fee Related
- 2002-02-20 EP EP06020790.9A patent/EP1844794B1/de not_active Expired - Lifetime
- 2002-02-20 DE DE60216234T patent/DE60216234T2/de not_active Expired - Lifetime
- 2002-02-20 ES ES02700440T patent/ES2275831T3/es not_active Expired - Lifetime
- 2002-02-20 AT AT02700440T patent/ATE345821T1/de not_active IP Right Cessation
- 2002-02-20 WO PCT/GB2002/000721 patent/WO2002067998A2/en active IP Right Grant
- 2002-02-20 AU AU2002233513A patent/AU2002233513B2/en not_active Expired
- 2002-02-20 EP EP02700440A patent/EP1361899B1/de not_active Expired - Lifetime
- 2002-02-20 NZ NZ527363A patent/NZ527363A/en not_active IP Right Cessation
- 2002-02-20 JP JP2002567362A patent/JP4594587B2/ja not_active Expired - Lifetime
-
2008
- 2008-12-24 JP JP2008327809A patent/JP5280188B2/ja not_active Expired - Lifetime
-
2011
- 2011-12-08 US US13/314,239 patent/US8647603B2/en not_active Expired - Lifetime
-
2014
- 2014-01-08 US US14/149,881 patent/US20140193335A1/en not_active Abandoned
-
2016
- 2016-09-02 US US15/255,220 patent/US20160367709A1/en not_active Abandoned
-
2017
- 2017-12-15 US US15/843,010 patent/US20180333509A1/en not_active Abandoned
-
2019
- 2019-10-10 US US16/598,285 patent/US20200206372A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0104383D0 (en) | 2001-04-11 |
EP1844794B1 (de) | 2017-05-03 |
EP1361899A2 (de) | 2003-11-19 |
CA2439062C (en) | 2010-06-22 |
EP1361899B1 (de) | 2006-11-22 |
WO2002067998A3 (en) | 2003-02-20 |
JP2004528300A (ja) | 2004-09-16 |
DE60216234T2 (de) | 2007-10-04 |
NZ527363A (en) | 2005-02-25 |
US20200206372A1 (en) | 2020-07-02 |
JP4594587B2 (ja) | 2010-12-08 |
US20160367709A1 (en) | 2016-12-22 |
US20180333509A1 (en) | 2018-11-22 |
AU2002233513B2 (en) | 2007-03-01 |
JP5280188B2 (ja) | 2013-09-04 |
CA2439062A1 (en) | 2002-09-06 |
US8647603B2 (en) | 2014-02-11 |
WO2002067998A2 (en) | 2002-09-06 |
DE60216234D1 (de) | 2007-01-04 |
US8097236B2 (en) | 2012-01-17 |
US20120076723A1 (en) | 2012-03-29 |
US20140193335A1 (en) | 2014-07-10 |
US20040091421A1 (en) | 2004-05-13 |
ES2275831T3 (es) | 2007-06-16 |
JP2009102365A (ja) | 2009-05-14 |
EP1844794A1 (de) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE345821T1 (de) | Radionuklide enthaltendes silikon-implantat für brachytherapie | |
DE60228096D1 (en) | Gewebtes orthopädisches implantat | |
HK1081866A1 (en) | Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation | |
AU7725700A (en) | Implantable stimulation device for snoring treatment | |
EP1648339A4 (de) | Implantierbare prothesenvorrichtungen insbesondere für die transarterielle abgabe bei der behandlung von aortenstenose und implantationsverfahren für diese vorrichtungen | |
DE60239707D1 (de) | Antimikrobielle kationische peptide und diese enthaltende formulierungen | |
AU2003301256A8 (en) | Timed delay for redelivery of treatment therapy for a medical device system | |
AU5977401A (en) | Delivery devices for treatment of vascular disease | |
GB0102672D0 (en) | Compounds | |
GR20020100478A (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης | |
ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
AU2003237969A8 (en) | Pharmaceutical composition comprising calcium channel blockers for the treatment of pain | |
IL170519A (en) | Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them | |
AU2003217971A8 (en) | Gas-plasma treatment of implants | |
EP1595536A4 (de) | Arzneimittel mit shikonin als wirkstoff | |
NO20020784D0 (no) | Medikament for behandling av brudd | |
ITRM20000652A0 (it) | Pilastro di guarigione per immobilizzazione intrachirurgica di impianti dentali per carico immediato. | |
NO20054034L (no) | Fremgangsmate for behandling av hypotyroidisme. | |
AU2003226276A1 (en) | Oxygen enriched implant for orthopedic wounds | |
GB9505082D0 (en) | Medicament | |
CY1107037T1 (el) | Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου | |
GB0207843D0 (en) | Device for use in treatment of infected endoprosthetic implants | |
AU2003281836A8 (en) | Implant for the treatment of presbyopia | |
EP1723961A3 (de) | Pharmazeutische Zusammensetzung, enthaltend wenigstens ein bone morphogenetic protein (BMP) | |
IL170738A (en) | Solid oral delivery device for the treatment of periodontal disease and periodontal implant comprising such |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |